Patent · US Active

Composition containing active components of Dracocephalum moldavica L. against myocardial ischemia-reperfusion injury

US10369165B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

NANJING RUIYING RUNZE BIOPHARMAEUTICAL TECHNOLOGY CO., INC. · CN

Inventors

Jing Shang · Fishers, US
Dongsheng Yu · 安丰镇, CN
Youqing Tian · 安丰镇, CN
Huali Wu · 安丰镇, CN
Lin Ding · 安丰镇, CN
Jun Liu · 安丰镇, CN

Key dates

Filing date	Mar 6, 2015
Grant date	Aug 6, 2019
Priority date	—
Expiry date	Mar 6, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a composition containing active components of Dracocephalum moldavica L. against myocardial ischemia-reperfusion injury (MIRI). The composition consists of active components and a pharmaceutically acceptable carrier, wherein the active components comprise luteolin, kaempferol and luteolin-7-O-glucoside. Pharmacodynamic experiments show that these three components can be combined together to synergistically treat myocardial ischemia-reperfusion injury.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.